Wolverine Trading, LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $300,687 - $362,956	7,300 New	7,300 $324,000
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $232,388 - $379,429	10,900 New	10,900 $318,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $152,178 - $266,292	7,800 New	7,800 $223,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $159,732 - $268,812	-5,400 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $226,368 - $314,172	5,400 New	5,400 $250,000
Q2 2021 Aug 06, 2021	SELL	$52.06 - $61.27 $390,450 - $459,525	-7,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $508,644 - $661,250	-11,500 Reduced 60.53%	7,500 $369,000
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $358,668 - $502,632	10,800 Added 131.71%	19,000 $846,000
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $142,254 - $234,906	-4,200 Reduced 33.87%	8,200 $282,000
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $272,155 - $422,492	-7,900 Reduced 38.92%	12,400 $657,000
Q1 2020 May 11, 2020	BUY	$31.52 - $53.81 $639,856 - $1.09 Million	20,300 New	20,300 $719,000
Q4 2019 Feb 12, 2020	SELL	$30.08 - $50.59 $586,560 - $986,505	-19,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $51,840 - $79,328	1,600 Added 8.94%	19,500 $672,000
Q2 2019 Aug 20, 2019	SELL	$46.17 - $68.1 $378,594 - $558,420	-8,200 Reduced 31.42%	17,900 $893,000
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $110,208 - $162,408	2,400 Added 10.13%	26,100 $1.76 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $1.01 Million - $1.81 Million	23,700 New	23,700 $1.07 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.